— Ticker · NMS —
INCY · Incyte Corporation
Healthcare · Biotechnology
INCY
$105.12
▲ +7.99%
7-day move
7-day move
day$100.82 → $105.3652-wk$66.74 → $112.29avg vol1.5M / 3Mcap$21.0B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 11.6 |
| P/E (trailing) | 14.8 |
| EPS (forward) | $9.07 |
| EPS (trailing) | $7.08 |
| PEG | 0.36 |
| Dividend | — |
The Risk
| Beta | 0.79 |
| Short % float | 9.52% |
| Float | 167.8M |
| Shares out | 199.8M |
| Avg vol (3M) | 1.5M |
| 52w range | $66.74 → $112.29 |
The Analyst Tape
strong buybuyholdunderperformsell
$107.96
avg 12-mo target
+2.7%
vs. last · 24 analysts
The Pipeline
$21.0B
market cap
exchangeNMS
sectorHealthcare
industryBiotechnology
market cap$21.0B
websiteincyte.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for INCY in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for INCY.
Indicators That Mention INCY
8 of our 639 catalog map to INCY
SP-1139
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-2967
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1253
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.02
SP-1346
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3489
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3062
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3534
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3555
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 639 indicators against four horizons. By chance alone, ~128 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.Other Players in the Pipeline
Biotech · by market cap · 7-day move
— Voices on INCY —commentarylive
Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning INCY. Opinion, not wire.
No recent commentary mentioning INCY in the last 7 days.
Analyst · previewYou're seeing the public read on INCY. Analyst unlocks every pundit call on INCY with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with INCY as the target + the API / MCP feed.Compare tiers →